Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03471546 : Early Palliative Care Intervention in Malignant Glioma
PhaseN/A
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- = 18 years of age

- Patient must have histologically confirmed, newly diagnosed WHO grade IV malignant
glioma (confirmation from biopsy, sub-total, or gross-total resection)

- Tumor must be de novo grade IV malignant glioma (i.e. NOT transformed from a lower
grade)

- Patient should be planning to receive standard chemoradiation (3 or 6 week protocols
are acceptable)

- Treating neuro-oncologist agrees to the patient's participation in this clinical trial

- Patient should be able to read and write English

Exclusion Criteria:

- Patient who currently has a PC provider and/or is receiving hospice care or plans on
initiating hospice at the time of enrollment
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT03471546      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740